- Home
- APLT vs IDR Comparison
APLT vs IDR Comparison
Compare APLT & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- IDR
- Stock Information
- Founded
- APLT 2016
- IDR 1996
- Country
- APLT United States
- IDR United States
- Employees
- APLT N/A
- IDR N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- IDR Precious Metals
- Sector
- APLT Health Care
- IDR Basic Materials
- Exchange
- APLT Nasdaq
- IDR Nasdaq
- Market Cap
- APLT 128.0M
- IDR 142.7M
- IPO Year
- APLT 2019
- IDR N/A
- Fundamental
- Price
- APLT $0.65
- IDR $11.21
- Analyst Decision
- APLT Buy
- IDR Strong Buy
- Analyst Count
- APLT 7
- IDR 1
- Target Price
- APLT $6.10
- IDR $14.00
- AVG Volume (30 Days)
- APLT 7.5M
- IDR 128.7K
- Earning Date
- APLT 03-05-2025
- IDR 11-04-2024
- Dividend Yield
- APLT N/A
- IDR N/A
- EPS Growth
- APLT N/A
- IDR 344.27
- EPS
- APLT N/A
- IDR 0.52
- Revenue
- APLT N/A
- IDR $21,955,008.00
- Revenue This Year
- APLT N/A
- IDR $86.37
- Revenue Next Year
- APLT $2,622.90
- IDR $11.11
- P/E Ratio
- APLT N/A
- IDR $21.73
- Revenue Growth
- APLT N/A
- IDR 64.93
- 52 Week Low
- APLT $0.60
- IDR $5.66
- 52 Week High
- APLT $10.62
- IDR $18.35
- Technical
- Relative Strength Index (RSI)
- APLT 20.60
- IDR 53.86
- Support Level
- APLT $0.60
- IDR $10.06
- Resistance Level
- APLT $0.74
- IDR $10.81
- Average True Range (ATR)
- APLT 0.09
- IDR 0.45
- MACD
- APLT 0.21
- IDR 0.17
- Stochastic Oscillator
- APLT 13.53
- IDR 93.27
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.